ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,826.00
      -0.10%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.605
      -0.87%
      Bitcoin
      62,743.44
      -3.25%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. International Stem Cell Corporation (QB) (ISCO)

      7. International Stem Cell Corporation (QB) (ISCO) News

      ISCO

      International Stem Cell (QB) (ISCO)

      International Stem Cell Corporation (QB)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:ISCO
      DateTimeSourceHeadlineSymbolCompany
      10/31/20179:00AMInvestorsHub NewsWireInternational Stem Cell Corporation Receives Key Stem Cell Patent in AustraliaUSOTC:ISCOInternational Stem Cell Corporation (QB)
      10/09/20178:30AMInvestorsHub NewsWireInternational Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver DiseasesUSOTC:ISCOInternational Stem Cell Corporation (QB)
      10/02/20177:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      10/02/20177:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      10/02/20177:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      09/26/20178:30AMInvestorsHub NewsWireInternational Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Clinical TrialsUSOTC:ISCOInternational Stem Cell Corporation (QB)
      09/20/20178:30AMInvestorsHub NewsWireInternational Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
      09/13/20178:30AMInvestorsHub NewsWireInternational Stem Cell Corporation is Valued at Over 400% of Its Current Market Value by Edison Investment ResearchUSOTC:ISCOInternational Stem Cell Corporation (QB)
      09/07/20172:31PMInvestorsHub NewsWireInternational Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's DiseaseUSOTC:ISCOInternational Stem Cell Corporation (QB)
      09/06/20174:53PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      08/30/20172:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      08/30/20171:46PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ISCOInternational Stem Cell Corporation (QB)
      08/25/20172:41PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      08/11/20174:43PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
      07/05/20175:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      07/05/20175:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      07/05/20175:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/15/20176:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/09/20173:11PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/08/201711:54AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/06/20173:10PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/02/20171:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/02/20171:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/02/20171:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/01/20174:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/01/20174:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/01/20174:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      06/01/20174:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      05/24/20173:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      04/28/20176:23AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ISCOInternational Stem Cell Corporation (QB)
       Showing the most relevant articles for your search:USOTC:ISCO